Original Research

Burden of rare genetic variants in genes associated with cancer among Malawian cervical cancer patients

Samuel D. Gwayi, Tamiwe Tomoka, Emile R. Chimusa, George Fedoriw, Benjamin Kumwenda
African Journal of Laboratory Medicine | Vol 15, No 1 | a3073 | DOI: https://doi.org/10.4102/ajlm.v15i1.3073 | © 2026 Samuel D. Gwayi, Tamiwe Tomoka, Emile R. Chimusa, George Fedoriw, Benjamin Kumwenda | This work is licensed under CC Attribution 4.0
Submitted: 21 October 2025 | Published: 15 May 2026

About the author(s)

Samuel D. Gwayi, Department of Biomedical Sciences, School of Life Science and Allied Health Professions, Kamuzu University of Health Sciences, Blantyre, Malawi
Tamiwe Tomoka, Department of Medicine, University of North Carolina, Lilongwe Project, Lilongwe, Malawi
Emile R. Chimusa, Department of Human Genetics and Forensic Genetics, Northumbria University, Newcastle, United Kingdom
George Fedoriw, Department of Medicine, University of North Carolina, Lilongwe Project, Lilongwe, Malawi
Benjamin Kumwenda, Department of Biomedical Sciences, School of Life Science and Allied Health Professions, Kamuzu University of Health Sciences, Blantyre, Malawi; and, Department of Food Biotechnology, University of Johannesburg, Johannesburg, South Africa

Abstract

Background: Cervical cancer (CC) is one of the most common cancer types affecting women globally. Cervical cancer is largely associated with human papillomavirus infections; however, approximately 5% to 11% of CC cases are non-human papillomavirus virus-related. Malawi has the second highest CC prevalence and mortality rate worldwide.
Objective: This study investigated the burden of rare genetic variants in genes associated with CC among Malawian women.
Methods: Ethical approval was obtained from the National Health Science Research committee on 28 August 2023. Whole-genome sequencing was performed on 20 Malawian CC patients, followed by variant discovery and annotation using the Genome Analysis Toolkit and Ensembl’s Variant Effector Predictor. Test for Rare Variants Against Public Database was performed on qualifying variants using 76 156 genomes from the Genome Aggregation database as controls. Bonferroni correction was applied to account for multiple testing.
Results: We identified 372 genes with a significant burden of rare variants (p < 0.05), including FAT1 (p = 0.0003), a known tumour suppressor gene associated with CC. After Bonferroni correction (p < 6.7×10−05), significance shifted to HTR3B, EPHA8, ABCC2, and SEC23B genes linked to various cancer types.
Conclusion: A significant burden of rare variants associated with CC was observed in known genes associated with lung, ovarian and osteosarcoma cancers, suggesting an increased population risk of developing CC and other cancers among Malawian women that needs further investigation.
What this study adds: The high burden of rare variants in the FAT1 gene, and a significant rare–variant burden in other cancer associated genes, supports a broader CC genetic risk and possible novel roles requiring further exploration.


Keywords

cervical cancer; human papillomavirus; whole genome sequencing; qualifying variants; rare variants; Malawian women

Sustainable Development Goal

Goal 3: Good health and well-being

Metrics

Total abstract views: 516
Total article views: 290


Crossref Citations

No related citations found.